Design procedures for gas sparged contractors for both low and high viscosity liquids were developed to predict overall kLa. Bubble size close to the orifice, for moderately high gas rates, was found to increase at a rate proportional to one third power of gas rate and one tenth power of liquid viscosity. Bubble breakup phenomenon was shown to be related to liquid turbulence in the vessel rather than gas turbulence in the orifice. Procedures were developed through a simple liquid circulation model to obtain a criterion for the onset of bubble breakup. Results indicate that intense liquid mixing and high interfacial area can be achieved in low viscosity liquids by gas sparging alone. In high viscosity fluids, bubble breakup was not observed. The liquid circulation model predicts laminar flow at these experimental conditions over the complete range of gas rates observed.
The Sherwood number and drag coefficient for a single gas bubble moving in a power law fluid and a Bingham plastic fluid are obtained using perturbation methods. The perturbation parameters for power law and Bingham plastic fluids are m (= n – 1/2) and E (= τ oR/U μ o), respectively. It is found that in the case of power law fluid, mass transfer and drag increase with increasing pseudoplasticity. These theoretical results are found to be in good agreement with the available experimental data and the data obtained in the present study. In the case of Bingham plastic fluid, mass transfer and drag are found to increase with increase in the Bingham number NB (= 2ε). Contours of plug flow regions, where local stresses are less than the yield stress, are obtained as a function of the Bingham number NB. These results qualitatively predict the zero terminal velocity observed for bubble motion in liquids with very high yield stress. They are also in good agreement with the trends of the results obtained previously for solid sphere motion in Bingham plastic fluids.
Three fatty acyl conjugates of (-)-2',3'-dideoxy-5-fluoro-3'-thiacytidine (FTC, emtricitabine) were synthesized and evaluated against HIV-1 cell-free and cell-associated virus and compared with the corresponding parent nucleoside and physical mixtures of FTC and fatty acids. Among all the compounds, the myristoylated conjugate of FTC (5, EC(50) = 0.07-3.7 μM) displayed the highest potency. Compound 5 exhibited 10-24 and 3-13-times higher anti-HIV activity than FTC alone (EC(50) = 0.7-88.6 μM) and the corresponding physical mixtures of FTC and myristic acid (14, EC(50) = 0.2-20 μM), respectively. Cellular uptake studies confirmed that compound 5 accumulated intracellularly after 1 h of incubation and underwent intracellular hydrolysis in CCRF-CEM cells. Alternative studies were conducted using the carboxyfluorescein conjugated with FTC though β-alanine (12) and 12-aminododecanoic acid (13). Acylation of FTC with a long-chain fatty acid in 13 improved its cellular uptake by 8.5-20 fold in comparison to 12 with a short-chain β-alanine. Compound 5 (IC(90) = 15.7-16.1 nM) showed 6.6- and 35.2 times higher activity than FTC (IC(90) = 103-567 nM) against multidrug resistant viruses B-NNRTI and B-K65R, indicating that FTC conjugation with myristic acid generates a more potent analogue with a better resistance profile than its parent compound.
The
present study demonstrates the relationship between conventional
and quantum mechanical (QM) NMR spectroscopic analyses, shown here
to assist in building a convincingly orthogonal platform for the solution
and documentation of demanding structures. Kaempferol-3-O-robinoside-7-O-glucoside, a bisdesmosidic flavonol
triglycoside and botanical marker for the aerial parts of Withania somnifera, served as an exemplary case. As demonstrated,
QM-based 1H iterative full spin analysis (HiFSA) advances
the understanding of both individual nuclear resonance spin patterns
and the entire 1H NMR spectrum of a molecule and establishes
structurally determinant, numerical HiFSA profiles. The combination
of HiFSA with regular 1D 1H NMR spectra allows for simplified
yet specific identification tests via comparison of high-quality experimental
with QM-calculated spectra. HiFSA accounts for all features encountered
in 1H NMR spectra: nonlinear high-order effects, complex
multiplets, and their usually overlapped signals. As HiFSA replicates
spectrum patterns from field-independent parameters with high accuracy,
this methodology can be ported to low-field NMR instruments (40–100
MHz). With its reliance on experimental NMR evidence, the QM approach
builds up confidence in structural characterization and potentially
reduces identity analyses to simple 1D 1H NMR experiments.
This approach may lead to efficient implementation of conclusive identification
tests in pharmacopeial and regulatory analyses: from simple organics
to complex natural products.
The goal of the qNMR Summit is to take stock of the status quo and the recent developments in qNMR research and applications in a timely and accurate manner. It provides a platform for both advanced and novice qNMR practitioners to receive a well-rounded update and discuss potential qNMR-related applications and collaborations. For over a decade, scientists from academia, industry, nonprofit institutions, and governmental bodies have focused on the standardization of qNMR methodology, as well as its metrological and pharmacopeial utility. This paper reviews key content of qNMR Summits 1.0 to 4.0 and puts into perspective the outcomes and available transcripts of the October 2019 Summit 5.0, with attendees from the United States, Canada, Japan, Korea, and several European countries. Summit presentations focused on qNMR methodology in the pharmaceutical industry, advanced quantitation algorithms, and promising developments.
NMR spectroscopy has recently been utilized to determine the absolute amounts of organic molecules with metrological traceability since signal intensity is directly proportional to the number of each nucleus in a molecule. The NMR methodology that uses hydrogen nucleus ( 1 H) to quantify chemicals is called quantitative 1 H-NMR ( 1 H qNMR). The quantitative method using 1 H qNMR for determining the purity or content of chemicals has been adopted into some compendial guidelines and official standards. However, there are still few reports in the literature regarding validation of 1 H qNMR methodology. Here, we coordinated an international collaborative study to validate a 1 H qNMR based on the use of an internal calibration methodology. Thirteen laboratories participated in this study, and the purities of three samples were individually measured using 1 H qNMR method. The three samples were all certified via conventional primary methods of measurement, such as butyl p-hydroxybenzoate Japanese Pharmacopeia (JP) reference standard certified by mass balance; benzoic acid certified reference material (CRM) certified by coulometric titration; fludioxonil CRM certified by a combination of freezing point depression method and 1 H qNMR. For each sample, 1 H qNMR experiments were optimized before quantitative analysis. The results showed that the measured values of each sample were equivalent to the corresponding reference labeled value. Furthermore, assessment of these 1 H qNMR data using the normalized error, E n -value, concluded that statistically 1 H qNMR has the competence to obtain the same quantification performance and accuracy as the conventional primary methods of measurement.
The E-1,3-diaminoethenyl functional group is a potentially useful synthon. A number of examples of E-1,3-diaminoethenyl functional groups were prepared in good yield starting from an E-enol tosylate of a serine based diketopiperazine and 1°-or 2° amine nucleophiles. The reaction proceeds via a stereoselective nucleophilic substitution pathway.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.